newswire, breaking biotechnology and pharma news

Wednesday, March 6, 2013

OTC Biotech Stock Alert; Bio-Matrix Scientific Group (OTC: BMSN) on the Run

Point Roberts, WA - March 6 2013 ( Newswire) staff:, an investor research portal specializing in sector research for independent investors issues a trading alert for microcap biotech stock, Bio-Matrix Scientific Group Inc. (OTC : BMSN ), currently trading at $0.0144, up 0.0010(7.46%) as of 10:11AM EST. The stock had a morning high of 0.0155. reported on the stock breaking previous trading patterns on February 15 th, noting a technical breakout. The stock pulled back and settled into another trading range that broke out in the past two days.
On February 5 th, Regen BioPharma a wholly-owned subsidiary of Bio-Matrix Scientific Group Inc. (OTC : BMSN ), announced filing of an Investigational New Drug (IND) application with the FDA to initiate clinical trials assessing the company's HemaXellerate I™ stem cell drug in patients with drug-refractory aplastic anemia.
HemaXellerate I™ is a patient-specific composition of cells that have previously been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies. The company, together with an internationally-renowned group of stem cell researchers, recently published the scientific basis for the HemaXellerate I™ product which may be found at
5 day chart Newswire About Bio-Matrix Scientific Group Inc. and Regen BioPharma, Inc.:
Bio-Matrix Scientific Group, Inc. (BMSN) is a biotechnology company developing regenerative medicine therapies. The Company is focused on human therapies that address unmet medical needs. Specifically, Bio-Matrix Scientific Group Inc. is looking to increase the quality of life through therapies involving stem cell treatments. These treatments are focused in areas relating to cardiovascular, hematology, oncology and other indications.
Regen BioPharma, Inc., a subsidiary of Bio-Matrix Scientific Group, Inc. ( PINKSHEETS : BMSN ), is a biotechnology company focused on identifying undervalued regenerative medicine patents in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. To follow our development, visit us at
OTC Markets
More info on BMSN:
As always, investors need to be aware of risks of investing in microcap OTC stocks.
About is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow on Twitter!/Investorideas
Follow on Facebook
Follow News on at
Sign up for the free investor news and stock alerts at
Become an Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
Disclaimer/ Disclosure : The is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: is long BMSN but has not been compensated for this report.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:
800-665-0411 - Source -

No comments:

Post a Comment